Revue Neurologique

Article	Citations
Neurological manifestations associated with SARS-CoV-2 and other coronaviruses: A narrative review for clinicians	152
Epidemiology of neurological diseases in older adults	60
High-clearance anti-amyloid immunotherapies in Alzheimer's disease. Part 1: Meta-analysis and review of efficacy and safety data, and medico-economical aspects	51
CGRP and migraine: from bench to bedside	48
Monoclonal antibodies blocking CGRP transmission: An update on their added value in migraine prevention	43
Neurofeedback for cognitive enhancement and intervention and brain plasticity	36
Impact of disease-modifying treatments on humoral response after COVID-19 vaccination: A mirror of the response after SARS-CoV-2 infection	30
Revised guidelines of the French headache society for the diagnosis and management of migraine in adults. Part 2: Pharmacological treatment	29
Pregnancy with multiple sclerosis	28
French guidelines for neuropathic pain: An update and commentary	27
Migraine with aura	26
Syringomyelia and hydromyelia: Current understanding and neurosurgical management	26
Melatonin (MEL) and its use in neurological diseases and insomnia: Recommendations of the French Medical and Research Sleep Society (SFRMS)	25
Clinical and genetic update of hereditary spastic paraparesis	24
Therapeutic news in ALS	24
Intensive care unit-acquired weakness: Questions the clinician should ask	21
Lafora disease: Current biology and therapeutic approaches	21
From competition to cooperation: Visual neglect across the hemispheres	20
FUS mutation is probably the most common pathogenic gene for JALS, especially sporadic JALS	20
Revised guidelines of the French headache society for the diagnosis and management of migraine in adults. Part 3: Non-pharmacological treatment	19
Spinal cord stimulation for neuropathic pain	19
Risk factors of severe COVID-19 in people with multiple sclerosis : A systematic review and meta-analysis	19
Brain plasticity and hearing disorders	19
Overview of the blood biomarkers in Alzheimer's disease: Promises and challenges	18
Genetics of migraine	18

French validation of the Brief International Cognitive Assessment for Multiple Sclerosis	18
Functional Neurological Disorders in the medical education: An urgent need to fill the gaps	17
Pathophysiology of Parkinson's disease: Mitochondria, alpha-synuclein and much more…	17
Stroke in women: When gender matters	17
Deep brain stimulation programming in Parkinson's disease: Introduction of current issues and perspectives	17
What is the link between migraine and psychiatric disorders? From epidemiology to therapeutics	17
Nonconvulsive status epilepticus in the elderly	17
No impact of confinement during COVID-19 pandemic on anxiety and depression in Parkinsonian patients	17
Cortical excitability in migraine: Contributions of magnetic resonance imaging	17
Intracerebral hemorrhage in CADASIL	16
Carotid webs associated with ischemic stroke. Updated general review and research directions	16
Spinal cord injury pain	16
Medical treatment of Rasmussen's Encephalitis: A systematic review	16
Relationships between migraine and epilepsy: Pathophysiological mechanisms and clinical implications	16
The effects of Alzheimer's and Parkinson's disease on 28-day mortality of COVID-19	15
The death of localizationism: The concepts of functional connectome and neuroplasticity deciphered by awake mapping, and their implications for best care of brain-damaged patients	15
Normal ageing of the brain: Histological and biological aspects	15
High-clearance anti-amyloid immunotherapies in Alzheimer's disease. Part 2: putative scenarios and timeline in case of approval, recommendations for use, implementation, and ethical considerations in	15
Future prophylactic treatments in migraine: Beyond anti-CGRP monoclonal antibodies and gepants	15
MRI characteristics of MOG-Ab associated disease in adults: An update	15
Association of obesity with recurrent stroke and cardiovascular events	15
Primary Lateral Sclerosis: Clinical, radiological and molecular features	15
Infections and multiple sclerosis: Recommendations from the French Multiple Sclerosis Society	15
Migraine in multiple sclerosis and other chronic inflammatory diseases	14
The management of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage	14
Neuropathy of the elderly	14
Artificial intelligence and ChatGPT between worst enemy and best friend: The two faces of a revolution and its impact on science and medical schools	14
Chronic pain in Parkinson's disease: Clinical and pathophysiological aspects	14
Imaging of the spine and spinal cord: An overview of magnetic resonance imaging (MRI) techniques	14
Spinal cord injury: A multisystem physiological impairment/dysfunction	14
Area postrema syndrome as initial manifestation in neuromyelitis optica spectrum disorder patients: A retrospective study	13
Revised guidelines of the French Headache Society for the diagnosis and management of migraine in adults. Part 1: Diagnosis and assessment	13
Self-perceived attention difficulties are associated with sensory hypersensitivity in migraine	13
Multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD) following COVID-19 vaccines: A systematic review	13
Neurological adverse events of immune checkpoint inhibitors: An update of clinical presentations, diagnosis, and management	13
Immunoglobulin shortage: Practice modifications and clinical outcomes in a reference centre	12
Phenotypic variability in amyotrophic lateral sclerosis	12
Will MRI replace the EEG for the diagnosis of nonconvulsive status epilepticus, especially focal?	12
The current international consensus criteria can lead to under and over-diagnosis of primary progressive aphasia variants	12
Long-term outcomes after NeuroCOVID: A 6-month follow-up study on 60 patients	12
Cerebrospinal fluid biomarkers in SARS-CoV-2 patients with acute neurological syndromes	11
Narcolepsies, update in 2023	11
Validation in French of the Montreal Cognitive Assessment 5-Minute, a brief cognitive screening test for phone administration	11
Disease-modifying therapy usage in patients with multiple sclerosis in France: A 6-year population-based study	10
Overcoming the blood brain barrier in glioblastoma: Status and future perspective	10
Prevalence of spasticity and spasticity-related pain among patients with Amyotrophic Lateral Sclerosis	10
Oral and intestinal dysbiosis in Parkinson's disease	10
Prevalence of stroke survivors in Parakou in northern Benin: A door-to-door community survey	10
Urinary tract infections and multiple sclerosis: Recommendations from the French Multiple Sclerosis Society	10
Guillain-Barré syndrome following first injection of ChAdOx1 nCoV-19 vaccine: First report	10

Steroid-responsive aseptic meningitis after BNT162b2 SARS-CoV-2 vaccine	10
Influence of inflammatory status in the acute phase of stroke on post-stroke depression	9
Challenges in diagnosis and management of adult spinal cord gliomas	9
Toward a coherent structuration of disorders of consciousness expertise at a country scale: A proposal for France	9
Clinical and biochemical markers in CIPN: A reappraisal	9
Melatonin (MEL) and its use in circadian rhythm sleep-wake disorders: Recommendations of the French Medical and Research Sleep Society (SFRMS)	9
Degenerative cervical myelopathy	9
Immunomodulation in the acute phase of autoimmune encephalitis	9
Beyond the amyloid cascade: An update of Alzheimer's disease pathophysiology	9
A first case of Mild Encephalitis with Reversible Splenial Lesion(MERS) as a presenting feature of SARS-CoV-2	9
EEG: Current relevance and promising quantitative analyses	9
Contribution of muscle MRI for diagnosis of myopathy	9
Recent advances in the diagnosis and the treatment of primary CNS lymphoma	9
Headache associated with refractive errors: Characteristics and risk factors	9
Interest of biological biomarkers in the diagnostic approach of neurocognitive disorders in the elderly	9
Therapeutic news in Alzheimer's disease: Soon a disease-modifying therapy?	9
Motor reserve: How to build neuronal resilience against ageing and neurodegeneration?	9
Genetics and familial distribution of multiple sclerosis: A review	9
Visual and motor neglect: Clinical and neurocognitive aspects	8
Prevalence and prospective evaluation of cognitive dysfunctions after SARS due to SARS-CoV-2 virus. The COgnitiVID study	8
Intracranial nociception	8
Therapeutic ultrasound: The future of epilepsy surgery?	8
Neuro-ChatGPT? Potential threats and certain opportunities	8
Nusinersen treatment in adults with severe spinal muscular atrophy: A real-life retrospective observational cohort study	8
Measles Sclerosing Subacute PanEncephalitis (SSPE), an intriguing and ever-present disease: Data, assumptions and new perspectives	8
Epilepsy and pregnancy: What should the neurologists do?	8
The role of neuropsychological assessment in adults with attention deficit/hyperactivity disorders	8
Resistance exercise relieves symptoms of vestibular migraine patients with MRI diagnosis: A randomized parallel-controlled single-blind clinical trial	8
Severe migraine and its control: A proposal for definitions and consequences for care	8
Evaluation of hypersomnolence: From symptoms to diagnosis, a multidimensional approach	8
Effects of glutathione S-transferase M1 and T1 deletions on Parkinson's disease risk among a North African population	8
Toxic-metabolic encephalopathy in adults: Critical discussion and pragmatical diagnostic approach	8
Myasthenia gravis and pregnancy	8
Arabic adaptation of the Edinburgh cognitive and behavioural Amyotrophic lateral sclerosis screen (ECAS-AR)	7
FOXP3 rs3761548 gene variant and interleukin-35 serum levels as biomarkers in patients with multiple sclerosis	7
Sleep and armed conflict: future complications of war in Ukraine	7
Metabolic alterations in spinal and bulbar muscular atrophy	7
Alexithymia in multiple sclerosis: Clinical and radiological correlations	7
What contribution can genetics make to predict the risk of Alzheimer's disease?	7
Endovascular therapy for acute ischemic stroke: The importance of blood pressure control, sedation modality and anti-thrombotic management to improve functional outcomes	7
Feasibility of changing for a rechargeable constant current neurostimulator in Parkinson's disease	7
Prognostic value of spinal cord MRI in multiple sclerosis patients	7
Intensive care management of patients with viral encephalitis	7
Cognitive deficit, and neuropathological correlates, in the oldest-old	7
Management of intramedullary spinal cord tumors: A single-center experience of 247 patients	7
Social and emotional cognition in patients with severe migraine consulting in a tertiary headache center: A preliminary study	7
Cannabis for the treatment of amyotrophic lateral sclerosis: What is the patients’ view?	7
Clinical description of the broad range of neurological presentations of COVID-19: A retrospective case series	7
Othello syndrome in Parkinson's disease: A diagnostic emergency of an underestimated condition	7
Epilepsy – from mysticism to science	6
Does ultrasound-guidance improve the outcome of botulinum toxin injections in cervical dystonia?	6
Diagnostic and therapeutic approach to adult central nervous system vasculitis	6
Interest of registries in neuropathic pain research	6
Late-onset neutropenia after anti-CD20 therapy for multiple sclerosis, neuromyelitis optica spectrum disorders and MOG antibody-associated disease: A prospective study	6
Identification and measurement of cervical spinal cord atrophy in neuromyelitis optica spectrum disorders (NMOSD) and correlation with clinical characteristics and cervical spinal cord MRI data	6
Medication overuse headache: Updating of the French recommendations regarding the treatment strategies	6
How to treat neurogenic bladder and sexual dysfunction after spinal cord lesion	6
Diaphragm ultrasound in the diagnosis of respiratory dysfunction in patients with amyotrophic lateral sclerosis	6
An inventory of basic research in temporal lobe epilepsy	6
Anatomical and neurophysiological basis of face recognition	6
Clinical and pathophysiological implications of autoantibodies in autoimmune neuropathies	6
Weaning from mechanical ventilation in neurocritical care	5
Hypometabolism on brain FDG-PET as a marker for neurotoxicity after CAR T-cell therapy: A case report	5
Dyskinesia and hyperpyrexia syndrome: A case report and review of the literature	5
Imaging of the aging brain and development of MRI signal abnormalities	5
Pregnancy and myopathies: Reciprocal impacts between pregnancy, delivery, and myopathies and their treatments. A clinical review	5
The COVID-19 pandemic, an environmental neurology perspective	5
Botulinum toxin for benign essential blepharospasm: A systematic review and an algorithmic approach	5
Insomnia in neurological disorders: Prevalence, mechanisms, impact and treatment approaches	5
Treatment of Charcot-Marie-Tooth neuropathies	5
How we sleep: From brain states to processes	5
ADAM10 as a biomarker for Alzheimer's disease: A systematic review	5
Beyond uncal herniation: An updated diagnostic reappraisal of ipsilateral hemiparesis and the Kernohan-Woltman notch phenomenon	5
Paradigm shifts in multiple sclerosis management: Implications for daily clinical practice	5
Headaches during pregnancy	5
Low back pain in patients with multiple sclerosis: A systematic review and the prevalence in a French multiple sclerosis population	5
General anesthesia or conscious sedation for endovascular therapy of basilar artery occlusions: ETIS registry results	5
Post infectious encephalitis at Covid19: About one pediatric observation and review of the literature	5
Brief International Cognitive Assessment for Multiple Sclerosis scores are associated with the cortical thickness of specific cortical areas in relapsing-remitting patients	5
Things you wanted to know (but might have been afraid to ask) about how and why to explore and modulate brain plasticity with non-invasive neurostimulation technologies	5

Does post dural puncture headache exist in idiopathic intracranial hypertension? A pilot study	5
Current treatments of spinal muscular atrophy in adults	5
Seizure incidence among neuromyelitis optica spectrum disorder patients	5
Changes in neuromuscular function in elders: Novel techniques for assessment of motor unit loss and motor unit remodeling with aging	5
Thirty years of progress in the management of low-grade gliomas	5
Strategy for genetic analysis in hereditary neuropathy	5
Intracerebral haemorrhage, microbleeds and antithrombotic drugs	5
Development and initial validation of the polyhandicap severity scale	5
Cerebral venous thrombosis in Behcet's disease. A report on 24 cases	5
High glycemic variability: An underestimated determinant of stroke functional outcome following large vessel occlusion	5
Spinal cord arterio-venous shunts: From classification to therapeutic management	5
Cerebrovascular events during pregnancy and puerperium	5
Electro-clinical presentation of hereditary transthyretin related amyloidosis when presenting as a polyneuropathy of unknown origin in northern France	5
Are there socio-economic inequities in access to reperfusion therapy: The stroke 69 cohort	4
Patients with Parkinson's disease and a history of falls have decreased cerebellar grey matter volumes in the cognitive cerebellum	4
Transcranial Doppler findings in a population with clinical probable reversible cerebral vasoconstriction syndrome	4
Reversible parkinsonism and FTD due to spontaneous intracranial hypotension	4
Spinal infarcts	4
Parkinsonian gait in elderly people: Significance of the threshold value of two and more falls per year	4
Ten-year follow-up after mitoxantrone induction for early highly active relapsing-remitting multiple sclerosis: An observational study of 100 consecutive patients	4
Neuro-Leptospirosis: Experience from a tertiary center of North India	4
Acute stroke care in France: Survey in the 138 stroke units	4
Tabes dorsalis in the 19th century. The golden age of progressive locomotor ataxia	4
Clinicoradiological and prognostic features of COVID-19-associated acute disseminated encephalomyelitis	4
Anglo-French neurological interactions in the 19th and early 20th centuries: Physicians, places and events	4
Early hyperdopaminergic state following sub-thalamic nucleus deep brain stimulation in Parkinson disease	4
An update on epidemiology, diagnosis & management of NMO-SD in the tertiary neurology department of Marrakech (Morocco)	4
Clinical, electrophysiological and genetic characteristics of childhood hereditary polyneuropathies	4
Mini review – The role of Glucocerebrosidase and Progranulin as possible targets in the treatment of Parkinson's disease	4
Neuropathy and pregnancy: An overview	4
Autologous tumor lysate-loaded dendritic cell vaccination in glioblastoma: What happened to the evidence?	4
High risk of osteoporotic fracture in Parkinson's disease: Meta-analysis, pathophysiology and management	4
Factors that predict a change in quality of life among Parkinson's disease patients participating in a patient education program	4
Management of glioblastomas in the elderly population	4
New onset refractory status epilepticus: State of the art	4
CSF biomarkers in primary CNS lymphoma	4
Acute and Post-Traumatic Stress Disorders: A biased nervous system	4
Associations between self-reported sleep quality and cerebrospinal fluid biomarkers in mild cognitive impairment and Alzheimer's disease	4
Sleepiness in neurological disorders	4
Treatment of hereditary amyotrophic lateral sclerosis	4
Postural tachycardia syndrome (POTS) and antiphospholipid syndrome (APS): What do we know so far?	4
Predictive factors of postoperative outcome in the elderly after resective epilepsy surgery	4
COVID-19: A putative trigger for neuralgic amyotrophy	4
The various forms of sensorimotor plasticity following limb amputation and their link with rehabilitation strategies	4
Iatrogenesis and neurological manifestations in the elderly	4
The Marquise de Dampierre identified at last, the first described clinical case of Gilles de la Tourette syndrome	4
VPS13D-based disease: Expansion of the clinical phenotype in two brothers and mutation diversity in the Turkish population	4
The new horizons for treatment of Late-Onset Pompe Disease (LOPD)	4
Konectom™ évaluation numérique sur smartphone des performances fonctionnelles cognitives et motrices dans la sclérose en plaques	4
Neuromuscular manifestations of lead poisoning in opium and herbal users in Iran	4
Oncological and functional neurosurgery: Perspectives for the decade regarding diffuse gliomas	4
Efficacy of microvascular decompression on the vascular compression type of neurogenic hypertension: A meta-analysis	3
Rationale for off-label treatments use in primary progressive multiple sclerosis: A review of the literature	3
Can Google Trends analysis confirm the public's need for information about the rare association of facial nerve paralysis with COVID-19 or the COVID-19 vaccination?	3
Impairment in oral medical comprehension in multiple sclerosis	3
French recommendations for the management of adult & pediatric chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)	3
New advances in Amyotrophic Lateral Sclerosis genetics: Towards gene therapy opportunities for familial and young cases	3
Epidemiological time-trend of amyotrophic lateral sclerosis (ALS) over two decades: The French population-based register of ALS in Limousin (FRALim register)	3
Spinal cord tractopathy in paraneoplastic anti-CV2/CRMP5 myelitis responsive to plasma exchange	3
Fluoxetine-induced chorea	3
Phenotype and management of neurologic intronic repeat disorders (NIRDs)	3
Challenges in diagnosis of motor neuron disease: A case series of ALS mimic syndromes	3
Left hemi-conus medullaris hematomyelia complicating oral anticoagulant therapy	3
How can we define the presymptomatic C9orf72 disease in 2022? An overview on the current definitions of preclinical and prodromal phases	3
AD and its comorbidities: An obstacle to develop a clinically efficient treatment?	3
Identification and characterization of repeat expansions in neurological disorders: Methodologies, tools, and strategies	3
Ethical issues in neurocritical care	3
Retrospective evaluation of regional telemedicine team meetings for multiple sclerosis (MS) patients: Experience from the Caen MS expert center in Normandy, France	3
Retinal vessels as a window on amyotrophic lateral sclerosis pathophysiology: A systematic review	3
Psycho-sensory modalities of visual hallucinations and illusions in Parkinson's disease	3
Immune-mediated necrotizing myopathy following vaccination with the AstraZeneca (AZD1222) COVID-19 vaccine: A case report and brief review	3
FXTAS patient presenting as Huntington-like generalized chorea	3
REM sleep function: Mythology vs. reality	3
Gene therapy review: Duchenne muscular dystrophy case study	3
Therapeutic tools for familial ALS	3
Non-infectious meningitis and CNS demyelinating diseases: A conceptual review	3
Antinuclear antibodies positivity is not rare during multiple sclerosis and is associated with relapsing status and IgG oligoclonal bands positivity	3
An educational case series of Parkinson's disease during the COVID-19 pandemic	3
Migralepsy, what it is and what it is not	3
Treating hereditary transthyretin amyloidosis: Present & future challenges	3
Awareness dimensions and associated factors in Alzheimer's disease	3
The strange Microenvironment of Glioblastoma	3
Suicide risk in epilepsy: Clinical variables, psychiatric disorders, and social support	3
Estimated number of eligible patients for mechanical thrombectomy based on NIHSS and population-based Brest stroke registry	3
Autoimmune cerebellar hypermetabolism: Report of three cases and literature overview	3
All that glitters is not gold: A limbic encephalitis due to neurosyphilis	3
Endogenous melatonin levels and therapeutic use of exogenous melatonin in tension type headache: A systematic review	3
Acute and subacute myelopathy	3
Henry Meige: The man and his understanding of dystonia, at the turn of the 19th to 20th century	3
Contrast enhanced ultrasound of carotid plaque in acute ischemic stroke (CUSCAS study)	3
Myelin oligodendrocyte glycoprotein associated disorder following SARS-CoV-2 vaccination	3
Factors affecting the outcome of delayed intravenous thrombolysis (> 4.5 hours)	3
Diagnostic and therapeutic issues of inflammatory diseases of the elderly	3
TICI-RANKIN mismatch: Poor clinical outcome despite complete endovascular reperfusion in the ETIS Registry	3
The effectiveness and safety of non-pharmacological intervention for pain management in Parkinson's disease: A systematic review	3